The success of Hungarian-developed products with reduced deuterium content in China

The HNC exhibition, held between June 24 and 26, where the Preventa deuterium-reduced drinking water product line, based on Hungarian discovery and development, was also introduced, attracted 2,500 exhibitors and 120,000 visitors from all over the world this year. The Preventa products were represented by the exclusive Chinese partner of the developer and manufacturer HYD Cancer Research and Drug Development Ltd., Nature Span, thereby increasing the awareness of the brand protected by international trademarks. The visual appearance of the Nature Span exhibition stand, the sophisticated brand brochures highlighting the unique benefits of deuterium-reduced drinking water products, made Preventa’s stand one of the most popular venues at the event, attracting hundreds of customers and potential reseller partners. Preventa’s new success creates a solid foundation for further promoting the product line and increasing sales in China, and draws attention to the importance of the work of Hungarian researchers and developers. Deuterium-reduced drinking water is not only popular in China, there is growing interest in low-deuterium food, dietary supplement and medical products worldwide. Research into the process, based on the principle of deuterium deprivation, based on a Hungarian scientific discovery, is ongoing at an international level, and domestic and foreign experts publish their results in prestigious professional journals. The European Commission’s Research Executive Agency (REA) is also supporting the studies, the aim of the ongoing research programme called Aqua-Synapse is to determine the optimal deuterium concentration for the body from the point of view of health preservation. HYD Cancer Research and Drug Development Ltd. is participating in the research as a member of the European consortium, in which the University of Lusófona and Institute of Molecular Medicine in Lisbon, the University Hospital of Würzburg, and the University of Oxford also played a significant role. HYD Ltd. aims to accelerate the development and global spread of its products, and to play a decisive role in the field of healthcare innovations.